A Discrete-Event Simulation of Smoking-Cessation Strategies Based on Varenicline Pivotal Trial Data

Author： Xenakis James G.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.29, Iss.6, 2011-06, pp. : 497-510

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost-Utility Analysis of Varenicline, an Oral Smoking-Cessation Drug, in Japan

By Igarashi Ataru  

PharmacoEconomics, Vol. 27, Iss. 3, 2009-01 ,pp. : 247-261

Adis International

Access to resources Recommend Favorite

Cost-Utility Analysis of Varenicline versus Existing Smoking Cessation Strategies using the BENESCO Simulation Model: Application to a Population of US Adult Smokers

By Howard Paul  

PharmacoEconomics, Vol. 26, Iss. 6, 2008-01 ,pp. : 497-511

Adis International

Access to resources Recommend Favorite

A cost-effectiveness model of smoking cessation based on a randomised controlled trial of varenicline versus placebo in patients with chronic obstructive pulmonary disease

By Lock Kevin   Wilson Koo   Murphy Daniel   Riesco Juan Antonio  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 17, 2011-12 ,pp. : 2613-2626

Informa Healthcare

Access to resources Recommend Favorite

Varenicline: progress in smoking cessation treatment

By Glover Elbert D   Rath Jessica M  

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 11, 2007-08 ,pp. : 1757-1767

Informa Healthcare

Access to resources Recommend Favorite

Varenicline: A Novel Pharmacotherapy for Smoking Cessation

By Jiménez-Ruiz Carlos  

Drugs, Vol. 69, Iss. 10, 2009-07 ,pp. : 1319-1338

Adis International

Access to resources Recommend Favorite